SEC Form 4 · accession 0001615774-18-001587
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher U Missling
Officer — Director, President & CEO · Director
Period of report
Mar 2, 2018
Accepted (ET)
Mar 5, 2018 · 8:56 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2018 | P | 1,650 | $2.41 | A | 1,013,900 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.